Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota are Attributable to Its Key Ingredient Berberine
Xizhan Xu, Zezheng Gao, Fuquan Yang, et al.
Genomics Proteomics & Bioinformatics (2020) Vol. 18, Iss. 6, pp. 721-736
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Gut microbiota: A new target for T2DM prevention and treatment
Lulu Liu, Jiheng Zhang, Yi Cheng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 92
Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus
Su Min, Rao Hu, Ting Tang, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 57
When short-chain fatty acids meet type 2 diabetes mellitus: Revealing mechanisms, envisioning therapies
Cong Xie, Cong Qi, Jianwen Zhang, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116791-116791
Open Access | Times Cited: 2
Mechanisms by Which Traditional Chinese Medicines Influence the Intestinal Flora and Intestinal Barrier
Qingya Che, Tingting Luo, Junhua Shi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 50
Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
Wenhui Liu, Zhiying Luo, Jiecan Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 38
The interplay between herbal medicines and gut microbiota in metabolic diseases
Lijie Wang, Xiaoling Gou, Yin Ding, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 31
Type 2 Diabetes (T2DM) and Parkinson’s Disease (PD): a Mechanistic Approach
S. Sri Sabari, Kiruthika Balasubramani, Mahalaxmi Iyer, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4547-4573
Open Access | Times Cited: 31
Modified Gegen Qinlian decoction ameliorated ulcerative colitis by attenuating inflammation and oxidative stress and enhancing intestinal barrier function in vivo and in vitro
Yifan Wang, Jiaqi Zhang, Beihua Zhang, et al.
Journal of Ethnopharmacology (2023) Vol. 313, pp. 116538-116538
Closed Access | Times Cited: 29
From Xiaoke to diabetes mellitus: a review of the research progress in traditional Chinese medicine for diabetes mellitus treatment
Xianglong Meng, Xiaoqin Liu, Jiaying Tan, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 27
Double-blinded, randomized clinical trial of Gegen Qinlian decoction pinpoints Faecalibacterium as key gut bacteria in alleviating hyperglycemia
Zezheng Gao, Wenhui Zhang, Lisha He, et al.
Precision Clinical Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 9
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Han Wang, Haiyu Zhang, Zezheng Gao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 33
Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples
Boxun Zhang, Ke Liu, Haoyu Yang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 32
Immunological regulation of the active fraction from Polygonatum sibiricum F. Delaroche based on improvement of intestinal microflora and activation of RAW264.7 cells
Yanfei He, Lin Huang, Ping Jiang, et al.
Journal of Ethnopharmacology (2022) Vol. 293, pp. 115240-115240
Closed Access | Times Cited: 31
Research progress on the pharmacological effects of berberine targeting mitochondria
Xinyi Fang, Haoran Wu, Jiahua Wei, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 31
Based on Network Pharmacology and Gut Microbiota Analysis to Investigate the Mechanism of the Laxative Effect of Pterostilbene on Loperamide-Induced Slow Transit Constipation in Mice
Zhiwei Yao, Siqi Fu, Bingbing Ren, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
Yu-Dian Zhou, Feng‐Xia Liang, Hao-Ran Tian, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 22
Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus
Juan Huang, Nanqu Huang, Qianhua Mao, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 21
Probiotic Fermentation of Herbal Medicine: Progress, Challenges, and Opportunities
Haoyu Yang, Lin Han, Yiqun Lin, et al.
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 05, pp. 1105-1126
Closed Access | Times Cited: 20
Study on the mechanism of modified Gegen Qinlian decoction in regulating the intestinal flora-bile acid-TGR5 axis for the treatment of type 2 diabetes mellitus based on macro genome sequencing and targeted metabonomics integration
Rong Liu, Jiahui Wang, Yi-Kun Zhao, et al.
Phytomedicine (2024) Vol. 132, pp. 155329-155329
Closed Access | Times Cited: 7
Metabolic disorders in prediabetes: From mechanisms to therapeutic management
Wen-Xin Ping, Shan Hu, Jingqian Su, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 361-377
Open Access | Times Cited: 6
GeGen QinLian decoction alleviate influenza virus infectious pneumonia through intestinal flora
Li Deng, Yucong Shi, Pei Liu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111896-111896
Open Access | Times Cited: 39
Berberine inhibits non‐small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis
Lulu Ni, Zhongjie Li, Hong‐Li Ren, et al.
Clinical and Experimental Pharmacology and Physiology (2021) Vol. 49, Iss. 1, pp. 134-144
Closed Access | Times Cited: 35
Modified Gegen Qinlian Decoction Regulates Treg/Th17 Balance to Ameliorate DSS-Induced Acute Experimental Colitis in Mice by Altering the Gut Microbiota
Yifan Wang, Jiaqi Zhang, Lin Xu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33
Regulation of the intestinal flora: A potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus
Liying He, Fangqing Yang, Pan Tang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113091-113091
Open Access | Times Cited: 23
The Role of Nutritional Factors in the Modulation of the Composition of the Gut Microbiota in People with Autoimmune Diabetes
Anna Winiarska‐Mieczan, Ewa Tomaszewska, Janine Donaldson, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2498-2498
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top